Assignee
SERAGON PHARMACEUTICALS INC
US·5 granted patents·2 pending applications·90 citations·filing 2012–2021
Top patents by PatentIndex Score
7 records- 0196US9078871B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Jul 14, 2015·50 cites·22 claims
- 0291US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 0388US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 0483US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 0578US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 0656US2022157469A1Methods of predicting age, and identifying and treating conditions associated with aging using spectral clustering and discrete cosine transformSERAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0750US2022136037A1Methods of predicting age, and identifying and treating conditions associated with agingSERAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SERAGON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →